HEADER TRANSFERASE 31-JAN-01 1I18 TITLE SOLUTION STRUCTURE OF THE N-TERMINAL DOMAIN OF RIBOFLAVIN SYNTHASE TITLE 2 FROM E. COLI COMPND MOL_ID: 1; COMPND 2 MOLECULE: RIBOFLAVIN SYNTHASE ALPHA CHAIN; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: N-TERMINAL DOMAIN, RESIDUES 1-97; COMPND 5 EC: 2.5.1.9; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI; SOURCE 3 ORGANISM_TAXID: 562; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS GREEK-KEY-BARREL, TRANSFERASE EXPDTA SOLUTION NMR NUMMDL 21 AUTHOR V.TRUFFAULT,M.COLES,T.DIERCKS,K.ABELMANN,S.EBERHARDT,H.LUETTGEN, AUTHOR 2 A.BACHER,H.KESSLER REVDAT 4 13-JUL-11 1I18 1 VERSN REVDAT 3 24-FEB-09 1I18 1 VERSN REVDAT 2 01-APR-03 1I18 1 JRNL REVDAT 1 05-SEP-01 1I18 0 JRNL AUTH V.TRUFFAULT,M.COLES,T.DIERCKS,K.ABELMANN,S.EBERHARDT, JRNL AUTH 2 H.LUTTGEN,A.BACHER,H.KESSLER JRNL TITL THE SOLUTION STRUCTURE OF THE N-TERMINAL DOMAIN OF JRNL TITL 2 RIBOFLAVIN SYNTHASE. JRNL REF J.MOL.BIOL. V. 309 949 2001 JRNL REFN ISSN 0022-2836 JRNL PMID 11399071 JRNL DOI 10.1006/JMBI.2001.4683 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: STRUCTURES BASED ON 2569 NOE RESTRAINTS REMARK 3 (353*2 INTRARES., 365*2 SEQUENTIAL, 159*2 MEDIUM-RANGE, 372*2 REMARK 3 LONG-RANGE, 71 INTERMOLECULAR) 56*2 DIHEDRAL RESTRAINTS, 42*2 H- REMARK 3 BONDS REMARK 4 REMARK 4 1I18 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 08-FEB-01. REMARK 100 THE RCSB ID CODE IS RCSB012778. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 300.00; 300.00; 300.00 REMARK 210 PH : 7.30; 7.30; 7.30 REMARK 210 IONIC STRENGTH : 50 MM; 50 MM; 50 MM REMARK 210 PRESSURE : AMBIENT; AMBIENT; AMBIENT REMARK 210 SAMPLE CONTENTS : 1 MM U-15N,13C RIBOFLAVIN REMARK 210 SYNTHASE + UNLABELLED RIBOFLAVIN; REMARK 210 1 MM U-15N RIBOFLAVIN SYNTHASE + REMARK 210 UNLABELLED RIBOFLAVIN; 1 MM U-15N REMARK 210 RIBOFLAVIN SYNTHASE + U-15N,13C REMARK 210 RIBOFLAVIN REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 3D_13C-SEPARATED_NOESY; NCH- REMARK 210 NOESY; CCH-NOESY; CNH-NOESY; 3D_ REMARK 210 15N-SEPARATED_NOESY; NNH-NOESY; REMARK 210 2D 12C-FILTERED-13C-EDITED NOESY; REMARK 210 HNHA REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ; 750 MHZ REMARK 210 SPECTROMETER MODEL : DMX REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : XWINNMR, AURELIA, X-PLOR REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 50 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 21 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LEAST REMARK 210 RESTRAINT VIOLATIONS REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 5 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 H ASN A 45 O ASN A 83 1.42 REMARK 500 H ASN B 45 O ASN B 83 1.42 REMARK 500 O THR A 67 HG1 THR A 71 1.55 REMARK 500 O THR B 67 HG1 THR B 71 1.56 REMARK 500 O ILE A 94 H GLY A 96 1.57 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 PHE A 2 139.50 179.98 REMARK 500 1 ASN A 45 14.12 54.01 REMARK 500 1 ASN A 55 63.22 -103.33 REMARK 500 1 GLU A 93 55.77 -158.87 REMARK 500 1 PHE B 2 139.57 -179.90 REMARK 500 1 ASN B 45 14.21 54.13 REMARK 500 1 ASN B 55 63.13 -103.33 REMARK 500 2 PHE A 2 139.98 -176.32 REMARK 500 2 THR A 3 -39.56 -130.06 REMARK 500 2 ASN A 45 11.29 55.64 REMARK 500 2 ASN A 55 64.25 -102.40 REMARK 500 2 GLU A 93 51.32 38.59 REMARK 500 2 PHE B 2 140.01 -178.50 REMARK 500 2 ASN B 45 11.48 55.90 REMARK 500 2 ASN B 55 64.32 -102.54 REMARK 500 3 PHE A 2 137.84 -173.22 REMARK 500 3 THR A 3 -31.78 -133.72 REMARK 500 3 PRO A 29 -178.50 -66.50 REMARK 500 3 ASN A 45 13.41 55.44 REMARK 500 3 ASN A 55 62.94 -104.20 REMARK 500 3 GLU A 93 52.85 38.92 REMARK 500 3 THR B 3 -31.95 -133.53 REMARK 500 3 PRO B 29 -178.53 -66.55 REMARK 500 3 ASN B 45 13.57 55.49 REMARK 500 3 ASN B 55 62.85 -104.20 REMARK 500 3 GLU B 93 54.11 -113.93 REMARK 500 4 PHE A 2 138.73 -179.33 REMARK 500 4 ASN A 45 16.34 51.83 REMARK 500 4 ASN A 55 65.25 -103.89 REMARK 500 4 GLU A 93 44.96 -95.72 REMARK 500 4 PHE B 2 138.55 -176.92 REMARK 500 4 ASN B 45 16.54 51.95 REMARK 500 4 ASN B 55 65.36 -104.04 REMARK 500 4 GLU B 93 48.58 -179.58 REMARK 500 5 THR A 3 -39.16 -150.49 REMARK 500 5 ASN A 45 12.86 54.82 REMARK 500 5 ASN A 55 65.72 -108.04 REMARK 500 5 THR B 3 -39.08 -150.46 REMARK 500 5 ASN B 45 12.88 55.01 REMARK 500 5 ASN B 55 65.74 -108.00 REMARK 500 6 ASN A 45 9.87 56.84 REMARK 500 6 ASN A 55 64.78 -104.92 REMARK 500 6 LEU A 63 100.42 -161.90 REMARK 500 6 GLU A 93 44.96 -88.29 REMARK 500 6 ASN B 45 9.77 57.13 REMARK 500 6 ASN B 55 64.82 -104.87 REMARK 500 6 LEU B 63 100.42 -161.94 REMARK 500 6 GLU B 93 54.15 -153.95 REMARK 500 7 THR A 3 -40.26 -151.79 REMARK 500 7 ASN A 45 11.49 58.22 REMARK 500 REMARK 500 THIS ENTRY HAS 194 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE RBF A 98 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE RBF B 99 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1HZE RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF THE N-TERMINAL DOMAIN OF RIBOFLAVIN REMARK 900 SYNTHASE FROM E. COLI DBREF 1I18 A 1 97 UNP P29015 RISA_ECOLI 1 97 DBREF 1I18 B 1 97 UNP P29015 RISA_ECOLI 1 97 SEQRES 1 A 97 MET PHE THR GLY ILE VAL GLN GLY THR ALA LYS LEU VAL SEQRES 2 A 97 SER ILE ASP GLU LYS PRO ASN PHE ARG THR HIS VAL VAL SEQRES 3 A 97 GLU LEU PRO ASP HIS MET LEU ASP GLY LEU GLU THR GLY SEQRES 4 A 97 ALA SER VAL ALA HIS ASN GLY CYS CYS LEU THR VAL THR SEQRES 5 A 97 GLU ILE ASN GLY ASN HIS VAL SER PHE ASP LEU MET LYS SEQRES 6 A 97 GLU THR LEU ARG ILE THR ASN LEU GLY ASP LEU LYS VAL SEQRES 7 A 97 GLY ASP TRP VAL ASN VAL GLU ARG ALA ALA LYS PHE SER SEQRES 8 A 97 ASP GLU ILE GLY GLY HIS SEQRES 1 B 97 MET PHE THR GLY ILE VAL GLN GLY THR ALA LYS LEU VAL SEQRES 2 B 97 SER ILE ASP GLU LYS PRO ASN PHE ARG THR HIS VAL VAL SEQRES 3 B 97 GLU LEU PRO ASP HIS MET LEU ASP GLY LEU GLU THR GLY SEQRES 4 B 97 ALA SER VAL ALA HIS ASN GLY CYS CYS LEU THR VAL THR SEQRES 5 B 97 GLU ILE ASN GLY ASN HIS VAL SER PHE ASP LEU MET LYS SEQRES 6 B 97 GLU THR LEU ARG ILE THR ASN LEU GLY ASP LEU LYS VAL SEQRES 7 B 97 GLY ASP TRP VAL ASN VAL GLU ARG ALA ALA LYS PHE SER SEQRES 8 B 97 ASP GLU ILE GLY GLY HIS HET RBF A 98 47 HET RBF B 99 47 HETNAM RBF RIBOFLAVIN HETSYN RBF RIBOFLAVINE; VITAMIN B2 FORMUL 3 RBF 2(C17 H20 N4 O6) HELIX 1 1 MET A 64 THR A 71 1 8 HELIX 2 2 ASN A 72 LEU A 76 5 5 HELIX 3 3 MET B 64 THR B 71 1 8 HELIX 4 4 ASN B 72 LEU B 76 5 5 SHEET 1 A 7 GLY A 8 LYS A 18 0 SHEET 2 A 7 PHE A 21 GLU A 27 -1 O PHE A 21 N LYS A 18 SHEET 3 A 7 HIS A 58 LEU A 63 -1 N VAL A 59 O VAL A 26 SHEET 4 A 7 CYS A 47 ASN A 55 -1 O THR A 50 N ASP A 62 SHEET 5 A 7 SER A 41 HIS A 44 -1 O VAL A 42 N LEU A 49 SHEET 6 A 7 TRP A 81 ALA A 87 -1 O GLU A 85 N ALA A 43 SHEET 7 A 7 GLY A 8 LYS A 18 -1 O GLY A 8 N VAL A 84 SHEET 1 B 7 GLY B 8 LYS B 18 0 SHEET 2 B 7 PHE B 21 GLU B 27 -1 O PHE B 21 N LYS B 18 SHEET 3 B 7 HIS B 58 LEU B 63 -1 N VAL B 59 O VAL B 26 SHEET 4 B 7 CYS B 47 ASN B 55 -1 O THR B 50 N ASP B 62 SHEET 5 B 7 SER B 41 HIS B 44 -1 O VAL B 42 N LEU B 49 SHEET 6 B 7 TRP B 81 ALA B 87 -1 O GLU B 85 N ALA B 43 SHEET 7 B 7 GLY B 8 LYS B 18 -1 O GLY B 8 N VAL B 84 SITE 1 AC1 9 CYS A 48 LEU A 49 THR A 50 ASP A 62 SITE 2 AC1 9 LEU A 63 MET A 64 THR A 67 ILE A 70 SITE 3 AC1 9 ILE B 5 SITE 1 AC2 9 ILE A 5 CYS B 48 LEU B 49 THR B 50 SITE 2 AC2 9 ASP B 62 LEU B 63 MET B 64 THR B 67 SITE 3 AC2 9 ILE B 70 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL MASTER 173 0 2 4 14 0 6 6 0 0 0 16 END